Detalhe da pesquisa
1.
CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals.
Clin Infect Dis
; 72(10): 1730-1737, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32198515
2.
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
Clin Infect Dis
; 73(6): 1003-1012, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822015
3.
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
N Engl J Med
; 379(4): 327-340, 2018 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897841
4.
The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.
J Infect Dis
; 221(7): 1057-1069, 2020 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755526
5.
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
J Infect Dis
; 217(4): 567-571, 2018 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325161
6.
Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia.
Pediatr Infect Dis J
; 39(4): e30-e36, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040014
7.
Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.
Vaccine
; 38(41): 6472-6477, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773243